Larimar Therapeutics, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:LRMR) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 200.22 M170.18 M149.99 M187.35 M145.84 M208.51 M 負債合計 28.41 M25.9 M30.13 M48.31 M67.76 M50.48 M 純資産合計 171.81 M144.27 M119.85 M139.04 M78.08 M158.03 M 負債および純資産合計 200.22 M170.18 M149.99 M187.35 M145.84 M208.51 M 有利子負債合計 —————— 純負債 ——————

ニュース

2 Companies Tackling the AI Bottlenecks

2 Breakout Stocks to Buy Immediately

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?

Wedbush、Larimar Therapeutics株の目標株価を12ドルに引き上げ

Wedbush raises Larimar Therapeutics stock price target to $12

Larimar Therapeutics: Deerfield関連主体が2500万ドル相当の株式を取得

Larimar Therapeutics: Deerfield entities buy $25m in stock

Larimar Therapeuticsの株価、1億ドルの増額公募により8%下落

Larimar Therapeutics stock falls 8% on upsized $100 million offering

Larimar Therapeutics、1株5ドルで1億ドルの株式公募を価格設定

Larimar Therapeutics prices $100M stock offering at $5 per share

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%